Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC
Clinical trial NCT04530227 · UNKNOWN
Trial details
- NCT number
- NCT04530227
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2025-06-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.